WND 8/31/2022
Protection increases with increased usage of politically charged drugA large study on the impact of using ivermectin as a prophylaxis for COVID-19 found that regular users of the drug experienced up to a 92% reduction in mortality compared to those who did not.
Brazilian research scientist Dr. Flavio A. Cadegiani said via Twitter that his study in his home country showed a "dose-response effect," meaning that "the more you used, the more protection you had."
He observed that people who use ivermectin regularly every 15 days for at least six to eight weeks had up to a 92% reduction in mortality.
Cadegiani conducted a previous study of drug that evaluated whether its use could impact COVID-19 infection and mortality rates.
Last fall, esteemed epidemiologist Dr. Harvey Risch of Yale Medical School was among scientists and physicians who said in Senate testimony that thousands of lives could have been saved if treatments such as ivermectin and hydroxychloroquine had not been suppressed.
-----
During the pandemic, Twitter and other social media platforms censored positive mention of ivermectin and hydroxychloroquine despite the countless testimonies and dozens of studies from around the world showing the drugs to be effective in treating COVID-19.
A follow-up FDA post said: "Also, a reminder that a study showed it didn't actually work against COVID."
Dr. Pierre Kory, who has testified to the Senate of the effectiveness of ivermectin against COVID-19, fired back.
"You are not a horse, you are not a cow, you are Big Pharma's ass," he tweeted.
The FDA, he wrote, was "messaging BS" by citing "one corrupt study" while ignoring 82 trials, including 33 randomized controlled trials with 129,000 patients from 27 countries that show "massive benefits" of ivermectin in treating COVID-19.
"Stop lying man, people are dying," he wrote, adding the hashtag "earlytreatmentworks."
More:
https://www.wnd.com/2022/08/new-ivermectin-study-shows-92-lower-chance-covid-death/
